National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results

< Back to Main
Page Options
Print This Page
E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

      
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Maintenance Rituximab for Follicular Lymphoma

Azacitidine Improves Survival in MDS

Second Stem Cell Transplant Not Helpful in Myeloma
Related Pages
Malignant Mesothelioma Home Page
NCI's gateway for information about malignant mesothelioma.

Search for Clinical Trials
NCI's PDQ® registry of cancer clinical trials.
Mesothelioma Trial Results
1.  Largest-Yet Mesothelioma Study Shows Survival Benefit with New Drug
(Posted: 05/20/2002, Reviewed: 03/15/2006) - Researchers with the largest phase III trial to date for mesothelioma, an aggressive cancer affecting the lining of the lung, reported results showing that patients on a new chemotherapy drug regimen live longer and have less pain than those on an older drug. The findings were announced at the annual meeting of the American Society of Clinical Oncology meeting in Orlando, Fla., on May 20, 2002.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov